Search Results | DrugBank Online

Displaying drugs 9826 - 9850 of 12697 in total

8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One

Experimental

2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide

Experimental

4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE

Experimental

N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide

Experimental

Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine

Experimental

Chlormadinone

Experimental

Matched Categories: … Sex Hormones and Modulators of the Genital System …

SOR-C13

SOR-C13 is under investigation in clinical trial NCT01578564 (Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel).

Investigational

Matched Iupac: … carbamoyl}-3-methylbutyl]carbamoyl}-2-phenylethyl]carbamoyl}-4-[(2S)-2,6-diaminohexanamido]butanoic acid …
Matched Description: … SOR-C13 is under investigation in clinical trial NCT01578564 (Safety and Tolerability Study of SOR-C13 …

Bis(5-Amidino-Benzimidazolyl)Methane

Experimental

2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate

Experimental

2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide

Experimental

Merimepodib

Merimepodib (VX-497) is a novel noncompetitive inhibitor of IMPDH. Merimepodib is orally bioavailable and inhibits the proliferation of primary human, mouse, rat, and dog lymphocytes at concentrations of approximately 100 nM.

Investigational

Matched Description: … lymphocytes at concentrations of approximately 100 nM. ... Merimepodib (VX-497) is a novel noncompetitive inhibitor of IMPDH. ... Merimepodib is orally bioavailable and inhibits the proliferation of primary human, mouse, rat, and dog …